Exposure to Bupropion-SR vs. Placebo is associated with reductions in smoking among persons receiving methadone with no stated interest in smoking cessation.

Ware, O. D., Stitzer, M. L., Umbricht, A., & Dunn, K. E. (2024). Exposure to Bupropion-SR vs. Placebo is associated with reductions in smoking among persons receiving methadone with no stated interest in smoking cessation. Addictive behaviors, 161, 108202. Advance online publication. https://doi.org/10.1016/j.addbeh.2024.108202.